Article
p53 mutation heterogeneity in cancer.
Biochemical and biophysical research communications - 10 Jun 2005
Soussi T, Lozano G
Abstract excerpt
The p53 gene is inactivated in about 50% of human cancers and the p53 protein is an essential component of the cell response induced by genotoxic stresses such as those generated by radiotherapy or chemotherapy. It is therefore highly likely that these alterations are an important component in tumor resistance to therapy. The particular characteristics of these alterations, 80% of which are missense mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
